Submacular hemorrhage
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with submacular hemorrhage in at least one eye; 2. Those who meet the syndrome differentiation criteria of yin deficiency and liver hyperactivity and heat injury of collaterals; 3. Over 18 years old; 4.Best corrected visual acuity (BCVA) measured by visual acuity chart: the letters of BCVA can be clearly seen by standard logarithmic visual acuity chart, ranging from 0.05 (including 0.1) to 0.6; 5. The refractive stroma is clear and does not interfere with fundus examination and fundus fluorescein angiography; 6. Patients should have good compliance with the observation and evaluation of the efficacy of the researchers; 7. Those who did not participate in other clinical trials within 2-4 weeks before treatment; 8. Those who sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Wet age-related macular degeneration was completely scarred without bleeding and exudation; 2. Fundus refractive stroma unclear (such as vitreous hemorrhage, cataract) affect the fundus condition of the observer; 3. Severe cardiovascular and cerebrovascular diseases, liver, kidney and hematopoiesis diseases; 4. Mental patients; 5. Severe allergy to sodium fluorescein injection; 6. Risk of thrombosis 7. Patients who are participating in clinical trials of other drugs; patients who use the same kind of traditional Chinese medicine and other treatments; or those who quit halfway.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vision improvement within 6 months; | — |
Countries
China
Contacts
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences